雜志介紹

Clinical Genitourinary Cancer雜志介紹

《Clinical Genitourinary Cancer》是一本以English為主的未開放獲取國際優秀期刊，中文名稱臨床泌尿生殖系癌，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.3，最新CiteScore 指數為5.2。

本刊近期中國學者發表的論文主要有：

• DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis

  Author: Lin, Yifei; Lin, Ling; Yang, Yong; Li, Mei; Jiang, Xin; Fu, Tingting; Long, Youlin; Guo, Qiong; He, He; Chen, Zhenglong; Du, Liang; Liao, Ga; Liao, Banghua; Huang, Jin

• Renal Cell Carcinoma Associated with t (6;11) Translocation/TFEB Gene Fusion: A Case Report and Review of Literature

  Author: Wang, Yiming; Xu, Guangjun; Yang, Haitao; Zhou, Xiaolong; Wen, Haitao

• Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival

  Author: Qiang, Yuanyuan; Wang, Xuhui; Ding, Jiangwei; Wang, Ziqin; Li, Bianli; Ji, Hui; Zhang, Xue; Yang, Yong; Liu, Kunmei; Zhang, Lianxiang; Ma, Shengmao; Zhao, Di; Lu, Guangyuan

• Surgical Management and Oncologic Outcomes for Local Retroperitoneal Recurrence of Renal Cell Carcinoma After Radical Nephrectomy

  Author: Huang, Jiwei; Wang, Yueming; Zhang, Cuijian; Hu, Xiaoyi; Wang, Ping; Shi, Guohai; Dong, Liang; Zhang, Jin; Kong, Wen; Chen, Yonghui; Xia, Dan; Guo, Jianming; Xue, Wei; Huang, Yiran; He, Zhisong

英文介紹

Clinical Genitourinary Cancer雜志英文介紹

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.